Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen nanoemulsion gel versus commercial ibuprofen gel for knee osteoarthritis pain
IRCT20150902023864N3Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ibuprofen in knee osteoarthritis (OA) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain and Skin irritation. Started Feb 2021; status: completed.
02
Drugs
ibuprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20150902023864N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150902023864N3.